You have 9 free searches left this month | for more free features.

City

Singapore (1)

Overall Status

Recruiting (1)

Sign in for free

Phase

phase 1 (1)

Sponsor

Novartis Pharmaceuticals (1)

Collaborator

Intervention

kfa115 (1)

tislelizumab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

kfa115

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

NSCLC, Cutaneous Melanoma, Carcinoma, Renal Cell Trial (KFA115, tislelizumab)

Recruiting

Carcinoma, Non-Small-Cell Lung
+10 more

KFA115
tislelizumab

Singapore, Singapore

Novartis Investigative Site

Nov 16, 2022